Ginkgo Bioworks: mini-bioreactor will speed expansion into pharma
Industrial microorganism design firm Ginkgo Bioworks expects to cut six months off development timelines using mini-bioreactor technology supplied by Sartorius Stedim Biotech (SSB).
Industrial microorganism design firm Ginkgo Bioworks expects to cut six months off development timelines using mini-bioreactor technology supplied by Sartorius Stedim Biotech (SSB).
Avid Bioservices has formally commissioned a biologics manufacturing facility that more than doubles its production capacity.